✦ LIBER ✦

First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial

✍ Scribed by Yang, James Chih-Hsin; Kang, Jin Hyoung; Mok, Tony; Ahn, Myung-Ju; Srimuninnimit, Vichien; Lin, Chia-Chi; Kim, Dong-Wan; Tsai, Chun-Ming; Barraclough, Helen; Altug, Sedat; Orlando, Mauro; Park, Keunchil

Book ID: 125817698
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 507 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.05.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P0066 A randomised phase 3 study compari

P0066 A randomised phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib as maintenance with gefitinib monotherapy in east Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer

✍ Yang, J.C-H.; Park, K.; Mok, T.; Kang, J.H.; Srimuninnimit, V.; Lin, C.-C.; Kim, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Randomized phase II trial of first-line

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer

✍ Ahn, Myung-Ju; Yang, James Chih-Hsin; Liang, Jun; Kang, Jin-Hyoung; Xiu, Qingyu; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Gefitinib versus placebo as maintenance

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

✍ Li Zhang; Shenglin Ma; Xiangqun Song; Baohui Han; Ying Cheng; Cheng Huang; Shuju 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 371 KB

Maintenance therapy with pemetrexed plus

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

✍ Luis Paz-Ares; Filippo de Marinis; Mircea Dediu; Michael Thomas; Jean-Louis Pujo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 244 KB

Induction Pemetrexed and Cisplatin Follo

Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life–Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer (ERACLE)

✍ Domenico Galetta; Salvatore Pisconti; Saverio Cinieri; Giovanni Luigi Pappagallo 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 235 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Schuette, Wolfgang H.W.; Gröschel, Andreas; Sebastian, Martin; Andreas, Stefan; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 534 KB